← Leaderboards
Rajiv Ravindra Mohan
University Of Missouri-Columbia
$11,125,675
Attributed
$12,802,893
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,802,893 · 9
VA$0 · 2
By mechanism
R01$7,140,891 · 3
U01$3,651,972 · 1
R21$1,279,790 · 3
R56$482,242 · 1
R43$247,998 · 1
I01$0 · 1
Top collaborators
- Shyam Sunder Chaurasia3 shared
- Suneel Gupta3 shared
- Ratnakar Tripathi3 shared
- Elizabeth Giuliano2 shared
- Praveen K Balne1 shared
- Rudolph Johnson1 shared
- Rudolph C Johnson1 shared
- Andrew Peter Mallon1 shared
Most similar at University Of Missouri-Columbia
Same institution · by research overlap
- Kattesh V Katti$3,115,330
Others in their field
Top investigators on “Blindness”
- Randall J Bateman · Washington University$137,189,188
- John M Lachin · George Washington University$122,970,601
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Beth Baseler · Leidos Biomedical Research, Inc.$111,479,515
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$96,562,493
Research focus
BlindnessCorneaIn VivoOryctolagus CuniculusFibrosisIn VitroMolecularAffectPreventTissuesGenesMediatingToxic EffectInjuryGene TherapyPublishingLeadCorneal DiseasesAmericanMyofibroblastPublicationsPilot ProjectsCorneal ScarInfection
Grant awards (54)
BLR&D Research Career Scientist Award Application (Renewal)$0
IK6 · FY2025 · VA · contact PI
Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur Mustard$718,856
U01 · FY2024 · EY · contact PI
Late/chronic corneal injury following threat chemical exposure$446,228
R01 · FY2024 · EY · contact PI
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases$0
I01 · FY2024 · VA · contact PI
BLR&D Research Career Scientist Award Application (Renewal)$0
IK6 · FY2024 · VA · contact PI
Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur Mustard$733,736
U01 · FY2023 · EY · contact PI
Mechanistic Understanding of Mustard Gas Toxicity in the Retina using a Minipig Model$482,242
R56 · FY2023 · EY
Late/chronic corneal injury following threat chemical exposure$455,992
R01 · FY2023 · EY · contact PI
BLR&D Research Career Scientist Award Application (Renewal)$0
IK6 · FY2023 · VA · contact PI
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases$0
I01 · FY2023 · VA · contact PI
Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur Mustard$740,416
U01 · FY2022 · EY · contact PI
Late/chronic corneal injury following threat chemical exposure$465,287
R01 · FY2022 · EY · contact PI
Novel approaches for corneal haze/fibrosis elimination$374,541
R01 · FY2022 · EY · contact PI
Hydrogen sulfide toxicity to the cornea$194,495
R21 · FY2022 · EY · contact PI
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases$0
I01 · FY2022 · VA · contact PI
BLR&D Research Career Scientist Award Application (Renewal)$0
IK6 · FY2022 · VA · contact PI
Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur Mustard$755,916
U01 · FY2021 · EY · contact PI
Novel approaches for corneal haze/fibrosis elimination$374,007
R01 · FY2021 · EY · contact PI
Development of a selective PI3K-Akt-activating neurotrophic small molecule drug, MT-002, for the healing of corneal wounds in Neurotrophic Keratitis.$247,998
R43 · FY2021 · EY
Hydrogen sulfide toxicity to the cornea$233,620
R21 · FY2021 · EY
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases$0
I01 · FY2021 · VA · contact PI
BLR&D Research Career Scientist Award Application (Renewal)$0
IK6 · FY2021 · VA · contact PI
Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur Mustard$703,048
U01 · FY2020 · EY · contact PI
Novel approaches for corneal haze/fibrosis elimination$384,750
R01 · FY2020 · EY · contact PI
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases$0
I01 · FY2020 · VA · contact PI
Novel approaches for corneal haze/fibrosis elimination$384,750
R01 · FY2019 · EY · contact PI
Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur Mustard$193,750
R21 · FY2019 · EY · contact PI
Nanomedicine Approach to Counteract Acrolien-induced Blindness and Toxicity to the Eye$193,475
R21 · FY2019 · EY · contact PI
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases$0
I01 · FY2019 · VA · contact PI
Gene Therapy in the Cornea$380,735
R01 · FY2018 · EY · contact PI
Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur Mustard$232,500
R21 · FY2018 · EY · contact PI
Nanomedicine Approach to Counteract Acrolien-induced Blindness and Toxicity to the Eye$231,950
R21 · FY2018 · EY · contact PI
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases$0
I01 · FY2018 · VA · contact PI
Gene Therapy in the Cornea$379,665
R01 · FY2017 · EY · contact PI
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases$0
I01 · FY2017 · VA · contact PI
Gene Therapy in the Cornea$379,665
R01 · FY2016 · EY · contact PI
Gene Therapy in the Cornea$31,515
R01 · FY2016 · EY · contact PI
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases$0
I01 · FY2016 · VA · contact PI
Gene Therapy in the Cornea$372,071
R01 · FY2015 · EY · contact PI
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases$0
I01 · FY2015 · VA · contact PI
Gene Therapy in the Cornea$392,978
R01 · FY2014 · EY · contact PI
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases$0
I01 · FY2014 · VA · contact PI
Gene Therapy in the Cornea$387,491
R01 · FY2012 · EY · contact PI
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases$0
I01 · FY2012 · VA · contact PI
Gene therapy in the cornea$319,091
R01 · FY2011 · EY · contact PI
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases$0
I01 · FY2011 · VA · contact PI
Gene therapy in the cornea$434,224
R01 · FY2010 · EY · contact PI
Gene therapy in the cornea$335,781
R01 · FY2009 · EY · contact PI
Gene therapy in the cornea$100,374
R01 · FY2009 · EY · contact PI
Gene therapy in the cornea$41,188
R01 · FY2009 · EY · contact PI
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases$0
I01 · FY2009 · VA · contact PI
Gene therapy in the cornea$329,082
R01 · FY2008 · EY · contact PI
Gene therapy in the cornea$337,053
R01 · FY2007 · EY · contact PI
Gene therapy in the cornea$34,423
R01 · FY2007 · EY · contact PI